162 related articles for article (PubMed ID: 28605064)
1. Characterization of the chloroquine-induced mouse model of pruritus using an automated behavioural system.
Tarrasón G; Carcasona C; Eichhorn P; Pérez B; Gavaldà A; Godessart N
Exp Dermatol; 2017 Nov; 26(11):1105-1111. PubMed ID: 28605064
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
[TBL] [Abstract][Full Text] [Related]
3. Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice.
Akiyama T; Carstens MI; Piecha D; Steppan S; Carstens E
Acta Derm Venereol; 2015 Feb; 95(2):147-50. PubMed ID: 24890341
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence of involvement of nitric oxide pathway in anti-pruritic effects of sumatriptan in chloroquine-induced scratching in mice.
Haddadi NS; Ostadhadi S; Shakiba S; Afshari K; Rahimi N; Foroutan A; Dehpour AR
Fundam Clin Pharmacol; 2018 Feb; 32(1):69-76. PubMed ID: 28815720
[TBL] [Abstract][Full Text] [Related]
5. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.
Inan S; Dun NJ; Cowan A
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576988
[TBL] [Abstract][Full Text] [Related]
6. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice.
Inan S; Dun NJ; Cowan A
Neuroscience; 2009 Sep; 163(1):23-33. PubMed ID: 19524022
[TBL] [Abstract][Full Text] [Related]
7. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
Umeuchi H; Togashi Y; Honda T; Nakao K; Okano K; Tanaka T; Nagase H
Eur J Pharmacol; 2003 Sep; 477(1):29-35. PubMed ID: 14512095
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
Nakao K; Togashi Y; Honda T; Momen S; Umeuchi H; Sakakibara S; Tanaka T; Okano K; Mochizuki H
Eur J Pharmacol; 2012 Nov; 695(1-3):57-61. PubMed ID: 22981641
[TBL] [Abstract][Full Text] [Related]
9. The NK1 receptor antagonist aprepitant attenuates NK1 agonist-induced scratching behaviour in the gerbil after intra-dermal, topical or oral administration.
Costantini VJ; Corsi M; Dünstl G; Bettelini L; Zonzini L; Gerrard P
Exp Dermatol; 2015 Apr; 24(4):312-4. PubMed ID: 25650546
[TBL] [Abstract][Full Text] [Related]
10. Possible Involvement of Nitric Oxide in the Antipruritic Effect of Metformin on Chloroquine-Induced Scratching in Mice.
Haddadi NS; Shakiba S; Afshari K; Haj-Mirzaian A; Vesaghati S; Gharagozlou S; Foroumadi R; Shafaroodi H; Ostadhadi S; Dehpour AR
Dermatology; 2020; 236(2):151-159. PubMed ID: 31437844
[TBL] [Abstract][Full Text] [Related]
11. Peripheral NMDA Receptor/NO System Blockage Inhibits Itch Responses Induced by Chloroquine in Mice.
Haddadi NS; Foroutan A; Ostadhadi S; Azimi E; Rahimi N; Nateghpour M; Lerner EA; Dehpour AR
Acta Derm Venereol; 2017 May; 97(5):571-577. PubMed ID: 28119997
[TBL] [Abstract][Full Text] [Related]
12. Effect of commercial and green synthesized ZnO NPs in murine model of chloroquine-induced pruritus.
Aman N; Rauf K; Khan SA; Tokhi A; Rehman NU; Yameen MA
Int J Nanomedicine; 2019; 14():3103-3110. PubMed ID: 31118625
[No Abstract] [Full Text] [Related]
13. [Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis].
Nakao K; Ikeda K; Kurokawa T; Togashi Y; Umeuchi H; Honda T; Okano K; Mochizuki H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):75-83. PubMed ID: 18516986
[TBL] [Abstract][Full Text] [Related]
14. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.
Inan S; Cowan A
Pharmacol Biochem Behav; 2006 Sep; 85(1):39-43. PubMed ID: 16919318
[TBL] [Abstract][Full Text] [Related]
15. Pentacyclic triterpenoids, alpha,beta-amyrins, suppress the scratching behavior in a mouse model of pruritus.
Oliveira FA; Lima-Junior RC; Cordeiro WM; Vieira-Júnior GM; Chaves MH; Almeida FR; Silva RM; Santos FA; Rao VS
Pharmacol Biochem Behav; 2004 Aug; 78(4):719-25. PubMed ID: 15301927
[TBL] [Abstract][Full Text] [Related]
16. Effects of Lecythis pisonis Camb. (Lecythidaceae) in a mouse model of pruritus.
Silva LL; Gomes BS; Sousa-Neto BP; Oliveira JP; Ferreira EL; Chaves MH; Oliveira FA
J Ethnopharmacol; 2012 Jan; 139(1):90-7. PubMed ID: 22063727
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
Trower MK; Fisher A; Upton N; Ratti E
Exp Dermatol; 2014 Nov; 23(11):858-60. PubMed ID: 25078633
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine-induced scratching is mediated by NO/cGMP pathway in mice.
Foroutan A; Haddadi NS; Ostadhadi S; Sistany N; Dehpour AR
Pharmacol Biochem Behav; 2015 Jul; 134():79-84. PubMed ID: 25957523
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a chloroquine-induced canine model of pruritus and skin inflammation.
Blubaugh A; Denley T; Banovic F
Vet Dermatol; 2020 Apr; 31(2):128-133. PubMed ID: 31774226
[TBL] [Abstract][Full Text] [Related]
20. An automated method for registering and quantifying scratching activity in mice: use for drug evaluation.
Elliott GR; Vanwersch RA; Bruijnzeel PL
J Pharmacol Toxicol Methods; 2000; 44(3):453-9. PubMed ID: 11395322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
